FDA clears first oral drug to treat postpartum depression or ‘baby blues’
HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after
HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after
HQ Team August 3, 2023: China is grappling with a rapid increase in mpox cases, formerly known as monkeypox, prompting concerns from the
HQ Team August 2, 2023: With global climate concerns at an all-time high, astronomer István Szapudi of the University of Hawaiʻi Institute for
HQ Team August 2, 2023: The key to increasing breastfeeding rates globally is to support and protect lactating mothers in the workplace, the
HQ Team August 2, 2023: There is a shortage of prescription stimulant medications in the US due to a manufacturing delay by one
HQ Team August 2, 2023: India’s Lupin Ltd., the eighth largest generic pharmaceutical company in the world based on revenue, has received the
HQ Team August 1, 2023: India has ordered a shutdown of a domestic pharmaceutical firm, whose cough syrup is believed to be behind
HQ Team August 1, 2023: Researchers from the Massachusetts Institute of Technology (MIT) have found that two common materials, cement and carbon black,
HQ Team August 1, 2023: A supercapacitor made of cement, water, and carbon black can store large amounts of energy and may form
HQ Team August 1, 2023: The US medical research agency has opened enrollment for the second stage of trials to evaluate about four treatments